DocGo (DCGO) Stock Forecast & Price Target

DocGo Inc. demonstrated a promising financial outlook with an EBITDA of $830,000, reflecting a 20% margin and indicating substantial margin gains expected from achieving greater economies of scale. Patient volumes in core service areas saw significant year-over-year growth, with medical transportation trips increasing by 11%, home visits rising by 113%, and telehealth services surging by 50%, highlighting strong demand for its mobile health offerings. Additionally, the company successfully increased its revenue and adjusted EBITDA guidance for 2026 by approximately $10 million, primarily driven by improved performance in its transportation segment while also projecting a transition to breakeven or modest profitability in the second half of the year.

DocGo Inc. has reported a decline in mobile revenue of 3% year-over-year and 8% quarter-over-quarter, excluding impacts from acquisitions and other factors, indicating struggles in revenue growth within its primary segment. The company requires a significant reduction in non-GAAP operating expenses, estimated between $20 to $22 million, to meet its adjusted EBITDA guidance for 2026, highlighting a concerning gap in profitability management amidst operational challenges. Furthermore, while the non-migrant Mobile Health segment reported a 47% year-over-year growth, the overall organic revenue growth is stagnating, as the core payer/provider businesses fail to scale as rapidly as anticipated, casting doubt on future revenue stability.